Quest 10 Wealth Builders, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 2035215
Fuquay-Varina, VA
Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$12,254
-$2,797 QoQ
Shares Held
97
-10.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,182
of 2,275 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quest 10 Wealth Builders, Inc. holds $1,239,103 across 11 Drug Manufacturers - General names. GILD ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,299 | $583,876 | |
| 2 | ABBV |
AbbVie Inc.
|
1,355 | $340,972 | |
| 3 | LLY |
ELI LILLY & Co
|
109 | $130,737 | |
| 4 | MRK |
Merck & Co., Inc.
|
623 | $80,055 | |
| 5 | PFE |
Pfizer Inc
|
2,092 | $50,375 | |
| 6 | GSK |
GSK plc
|
239 | $12,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
97 | $12,254 | |
| 8 | AZN |
Astrazeneca PLC
|
61 | $11,566 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,254 | 97 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $15,051 | 108 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $13,746 | 112 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $14,874 | 134 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $12,971 | 117 | Shares | Sole | 2025-10-20 | |
| 2025-03-31 | $13,782 | 123 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $13,577 | 147 | Shares | Other | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||